Fig. 4From: Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infectionLiposome-encapsulated levofloxacin nanoaerosol and standard aerosol. a Size distribution of nanoaerosolized liposome-encapsulated levofloxacin. b Survival curve of mice treated with nanoaerosolized liposome-encapsulated levofloxacin (blue) against 100LD50 intranasal F. novicida infection. c Survival curve of mice treated with aerosolized levofloxacin (30 min—red, 1 h—green, 2 h—blue) against 100LD50 intranasal F. novicida infectionBack to article page